{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL6",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0956" ]
    }
  },
  "verbose_text" : "Marked elevation of plasma soluble hIL6R and human IL6 levels was also observed in our mouse model similar to that reported by Nishimoto et al. in the patients with Castleman 's disease or rheumatoid arthritis that had been treated with tocilizumab XREF_BIBR.",
  "reading_complete" : "2020-08-04T09:02:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:01:17Z",
  "trigger" : "levels",
  "evidence" : [ "IL6 levels" ],
  "pmc_id" : "3561642",
  "score" : 0
}